Analysis

Despite reporting progress in its pivotal Phase 3 trial for a hepatitis C combination therapy, Atea Pharmaceuticals Inc. witnessed its...

Autolus Therapeutics presents investors with a compelling puzzle. The clinical-stage biopharmaceutical company boasts a recently approved cancer therapy and impressive...

The semiconductor sector's spotlight turns to Broadcom this week as the chip manufacturer prepares to report quarterly earnings. Having emerged...

PepGen Inc. finds itself navigating a perfect storm of declining investor confidence, legal challenges, and a strategic pipeline overhaul. The...

Healthcare services provider Mednax has captured market attention with a robust quarterly performance and a significant new capital return initiative....

While technology stocks dominate headlines, a specialized environmental services company is demonstrating remarkable operational and financial improvement. Montrose Environmental Group...

The age of boundless AI euphoria appears to be ending, at least for one specialist player. As the broad speculative...

Despite posting robust quarterly earnings and announcing a strategically significant partnership, Quest Diagnostics finds itself facing unexpected hesitation from Baird's...

Dropbox finds itself at a critical juncture as CEO Drew Houston champions artificial intelligence initiatives while major institutional investors demonstrate...

Achieving five consecutive decades of dividend growth is a rare corporate accomplishment, placing MGE Energy among an elite group of...